Apply to trial NCT07217600

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 4Drug trial

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

The goal of this study is to evaluate the antiemetic efficacy and drug safety of ondansetron orodispersible film in pediatric patients with malignant tumors who received moderate emetic risk radiation induced vomiting, and to formulate reasonable and effective clinical medication regimen for preventing vomiting caused by moderate emetic risk radiation in children with malignant tumor.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening